These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


606 related items for PubMed ID: 27267903

  • 1. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England.
    Moss S, Mathews C, Day TJ, Smith S, Seaman HE, Snowball J, Halloran SP.
    Gut; 2017 Sep; 66(9):1631-1644. PubMed ID: 27267903
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
    Murphy J, Halloran S, Gray A.
    BMJ Open; 2017 Oct 27; 7(10):e017186. PubMed ID: 29079605
    [Abstract] [Full Text] [Related]

  • 3. Gender-specific cut-offs in colorectal cancer screening with FIT: Increased compliance and equal positivity rate.
    Blom J, Löwbeer C, Elfström KM, Sventelius M, Öhman D, Saraste D, Törnberg S.
    J Med Screen; 2019 Jun 27; 26(2):92-97. PubMed ID: 30336730
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interval cancers in a national colorectal screening programme based on faecal immunochemical testing: Implications for faecal haemoglobin concentration threshold and sex inequality.
    Clark GR, Godfrey T, Purdie C, Strachan J, Carey FA, Fraser CG, Steele RJ.
    J Med Screen; 2024 Mar 27; 31(1):21-27. PubMed ID: 37469171
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Faecal haemoglobin concentration is related to detection of advanced colorectal neoplasia in the next screening round.
    Digby J, Fraser CG, Carey FA, Diament RH, Balsitis M, Steele RJ.
    J Med Screen; 2017 Jun 27; 24(2):62-68. PubMed ID: 27370211
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Experience with a two-tier reflex gFOBT/FIT strategy in a national bowel screening programme.
    Fraser CG, Digby J, McDonald PJ, Strachan JA, Carey FA, Steele RJ.
    J Med Screen; 2012 Mar 27; 19(1):8-13. PubMed ID: 22156144
    [Abstract] [Full Text] [Related]

  • 16. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A, Young GP, Cole SR, Bampton P.
    Cancer; 2006 Nov 01; 107(9):2152-9. PubMed ID: 16998938
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
    Arana-Arri E, Idigoras I, Uranga B, Pérez R, Irurzun A, Gutiérrez-Ibarluzea I, Fraser CG, Portillo I, EUSKOLON Group.
    BMC Cancer; 2017 Aug 29; 17(1):577. PubMed ID: 28851318
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.